Several Options for Frontline Treatment of MCL

In this MEDtalk from EHA 2025, Professor Mats Jerkeman, MD, PhD, from Lund University and Skåne University Hospital, highlights several possible frontline treatment strategies in mantle cell lymphoma that incorporate BTK inhibitors. He provides his perspective on frontline treatment strategies for younger MCL patients as well as older and high-risk patients.